The Kennedy's Disease Association is initiating a new funding opportunity for research into the molecular pathogenesis of Kennedy's Disease (Spinal and Bulbar Muscular Atrophy). The discovery of a polyglutamine expansion within the androgen receptor as cause of this degenerative neuromuscular disease has led to the elucidation of several potential therapeutic cellular targets. Research grants are being sought to further the understanding of pathogenic mechanisms in Kennedy's Disease, as well as to develop assays for drug screening and testing of candidate compounds. Funding for research grants will be $25,000 for one year.

          Deadlines:

          March 15, 2003 - Letters of Intent Due

          April 15, 2003 - SRB Announcement of Grant Proposal Requests

          May 15, 2003 - Full Grant Proposals Due

          June 30, 2003 -  KDA Awards Grant(s)

          July 1, 2003    - Grant Funded

Applications from junior investigators and from senior post-doctoral fellows are encouraged. Please send a letter of intent to the Scientific Advisory Board at:

Kennedy's Disease Association

 P.O. Box 1105, Coarsegold, CA  93614-1105 (U.S.A.)
(559) 658-5950 email: info@kennedysdisease.org